| Disease | Target Count | P-value |
|---|---|---|
| non-small cell lung cancer | 2890 | 2.5e-10 |
| cystic fibrosis | 1696 | 7.1e-05 |
| nasopharyngeal carcinoma | 1058 | 1.2e-04 |
| psoriasis | 6694 | 1.4e-03 |
| colon cancer | 1478 | 2.7e-03 |
| cutaneous lupus erythematosus | 1057 | 3.3e-03 |
| pancreatic cancer | 2398 | 4.0e-03 |
| intraductal papillary-mucinous neoplasm (IPMN) | 3291 | 8.5e-03 |
| cystic fibrosis and chronic rhinosinusitis | 214 | 1.5e-02 |
| lung cancer | 4740 | 1.8e-02 |
| esophageal adenocarcinoma | 737 | 2.4e-02 |
| Disease | log2 FC | p |
|---|---|---|
| colon cancer | 1.400 | 2.7e-03 |
| cutaneous lupus erythematosus | 3.500 | 3.3e-03 |
| cystic fibrosis | 4.700 | 7.1e-05 |
| cystic fibrosis and chronic rhinosinusit... | 1.125 | 1.5e-02 |
| esophageal adenocarcinoma | -4.400 | 2.4e-02 |
| intraductal papillary-mucinous neoplasm ... | 2.100 | 8.5e-03 |
| lung cancer | -4.900 | 1.8e-02 |
| nasopharyngeal carcinoma | -3.400 | 1.2e-04 |
| non-small cell lung cancer | 4.362 | 2.5e-10 |
| pancreatic cancer | 2.300 | 4.0e-03 |
| psoriasis | 1.200 | 1.4e-03 |
